261 related articles for article (PubMed ID: 8001894)
1. [The pharmacologic and clinical profile of the new anticonvulsant felbamate--an overview].
Steinhoff BJ
Fortschr Neurol Psychiatr; 1994 Oct; 62(10):379-88. PubMed ID: 8001894
[TBL] [Abstract][Full Text] [Related]
2. Felbamate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in epilepsy.
Palmer KJ; McTavish D
Drugs; 1993 Jun; 45(6):1041-1065. PubMed ID: 7691493
[TBL] [Abstract][Full Text] [Related]
3. Felbamate.
Sofia RD; Kramer L; Perhach JL; Rosenberg A
Epilepsy Res Suppl; 1991; 3():103-8. PubMed ID: 1777064
[No Abstract] [Full Text] [Related]
4. Felbamate.
Leppik IE
Epilepsia; 1995; 36 Suppl 2():S66-72. PubMed ID: 8784215
[TBL] [Abstract][Full Text] [Related]
5. Felbamate: a new antiepileptic drug.
Brodie MJ
Lancet; 1993 Jun; 341(8858):1445-6. PubMed ID: 8099147
[No Abstract] [Full Text] [Related]
6. Felbamate pharmacology and use in epilepsy.
Burdette DE; Sackellares JC
Clin Neuropharmacol; 1994 Oct; 17(5):389-402. PubMed ID: 9316688
[TBL] [Abstract][Full Text] [Related]
7. Felbamate.
Bourgeois BF
Semin Pediatr Neurol; 1997 Mar; 4(1):3-8. PubMed ID: 9097361
[TBL] [Abstract][Full Text] [Related]
8. Felbamate: clinical and molecular aspects of a unique antiepileptic drug.
Brown WM; Aiken SP
Crit Rev Neurobiol; 1998; 12(3):205-22. PubMed ID: 9847055
[TBL] [Abstract][Full Text] [Related]
9. [Felbamate: perspectives for new antiepileptic treatment].
Pérez-Miranda J; Aguirre J; Parrilla JL; Pérez Miranda M
Rev Neurol; 1995; 23(124):1220-5. PubMed ID: 8556622
[TBL] [Abstract][Full Text] [Related]
10. [Therapeutic drug monitoring of felbamate].
Tribut O; Bentué-Ferrer D; Verdier MC;
Therapie; 2010; 65(1):35-8. PubMed ID: 20205993
[TBL] [Abstract][Full Text] [Related]
11. Is there any future for felbamate treatment?
Borowicz KK; Piskorska B; Kimber-Trojnar Z; Małek R; Sobieszek G; Czuczwar SJ
Pol J Pharmacol; 2004; 56(3):289-94. PubMed ID: 15215558
[TBL] [Abstract][Full Text] [Related]
12. [New antiepileptic drugs: vagabatrin, lamotrigine and felbamate].
Herranz JL; Arteaga R; Armijo JA
Neurologia; 1994 Nov; 9(9):410-7. PubMed ID: 7811493
[No Abstract] [Full Text] [Related]
13. Felbamate: consensus of current clinical experience.
Pellock JM; Faught E; Leppik IE; Shinnar S; Zupanc ML
Epilepsy Res; 2006 Oct; 71(2-3):89-101. PubMed ID: 16889941
[TBL] [Abstract][Full Text] [Related]
14. Felbamate: successful development of a new compound for the treatment of epilepsy.
Schmidt D
Epilepsia; 1993; 34 Suppl 7():S30-3. PubMed ID: 8243376
[TBL] [Abstract][Full Text] [Related]
15. Felbamate in epilepsy therapy: evaluating the risks.
Pellock JM
Drug Saf; 1999 Sep; 21(3):225-39. PubMed ID: 10487399
[TBL] [Abstract][Full Text] [Related]
16. Felbamate: 1997 update.
Pellock JM; Brodie MJ
Epilepsia; 1997 Dec; 38(12):1261-4. PubMed ID: 9578519
[No Abstract] [Full Text] [Related]
17. Coadministration of phenytoin and felbamate: evidence of additional phenytoin dose-reduction requirements based on pharmacokinetics and tolerability with increasing doses of felbamate.
Sachdeo R; Wagner ML; Sachdeo S; Shumaker RC; Lyness WH; Rosenberg A; Ward D; Perhach JL
Epilepsia; 1999 Aug; 40(8):1122-8. PubMed ID: 10448826
[TBL] [Abstract][Full Text] [Related]
18. Felbamate.
Med Lett Drugs Ther; 1993 Nov; 35(910):107-9. PubMed ID: 8232064
[No Abstract] [Full Text] [Related]
19. Efficacy and safety of felbamate in children under 4 years of age: a retrospective chart review.
Grosso S; Cordelli DM; Coppola G; Franzoni E; Verrotti A; Berardi R; Balestri P
Eur J Neurol; 2008 Sep; 15(9):940-6. PubMed ID: 18637038
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of felbamate in therapy for partial epilepsy in children.
Carmant L; Holmes GL; Sawyer S; Rifai N; Anderson J; Mikati MA
J Pediatr; 1994 Sep; 125(3):481-6. PubMed ID: 8071763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
